Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Li-Hang Shen

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|March 10, 2021
Exosomes from Adipose-Derived Stem Cells Can Prevent Medication-Related Osteonecrosis of the JawXian Dong, Li-Hang Shen, Zheng Yi, et al.
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|April 5, 2019
High-Throughput Sequencing Analysis of Microbial Profiles in the Dry SocketLi-Hang Shen, E Xiao, En-Bo Wang, et al.
Oral Oncology|December 6, 2025
Neoadjuvant tislelizumab plus chemotherapy in locally advanced oral and oropharyngeal squamous cell carcinoma: A single-arm phase II clinical trialWen-Jie Wu, Pu-Gen An, Zi-Qi Zhang, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|March 10, 2021
Exosomes from Adipose-Derived Stem Cells Can Prevent Medication-Related Osteonecrosis of the JawXian Dong, Li-Hang Shen, Zheng Yi, et al.
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|April 5, 2019
High-Throughput Sequencing Analysis of Microbial Profiles in the Dry SocketLi-Hang Shen, E Xiao, En-Bo Wang, et al.
Oral Oncology|December 6, 2025
Neoadjuvant tislelizumab plus chemotherapy in locally advanced oral and oropharyngeal squamous cell carcinoma: A single-arm phase II clinical trialWen-Jie Wu, Pu-Gen An, Zi-Qi Zhang, et al.
Pageof 1